Chemoinformaics analysis of 2-alkyl-3-methoxypyrazines
| Molecular Weight | 138.17 | nRot | 2 |
| Heavy Atom Molecular Weight | 128.09 | nRig | 6 |
| Exact Molecular Weight | 138.079 | nRing | 1 |
| Solubility: LogS | -0.555 | nHRing | 1 |
| Solubility: LogP | 1.556 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 21.3599 |
| nHD | 0 | BPOL | 14.0481 |
| QED | 0.612 |
| Synth | 2.401 |
| Natural Product Likeliness | -0.904 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.317 |
| MDCK | 0.000037 |
| BBB | 0.741 |
| PPB | 0.329381 |
| VDSS | 1.328 |
| FU | 0.578321 |
| CYP1A2-inh | 0.387 |
| CYP1A2-sub | 0.707 |
| CYP2c19-inh | 0.069 |
| CYP2c19-sub | 0.859 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.583 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.678 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.278 |
| CL | 8.09 |
| T12 | 0.649 |
| hERG | 0.017 |
| Ames | 0.097 |
| ROA | 0.295 |
| SkinSen | 0.888 |
| Carcinogencity | 0.354 |
| EI | 0.949 |
| Respiratory | 0.898 |
| NR-Aromatase | 0.026 |
| Antiviral | No |
| Prediction | 0.905072 |